Denali Therapeutics (DNLI) Earnings Date
The next earnings date for Denali Therapeutics (DNLI) is around Feb 25, 2027, estimated from its own calendar.
- Next earnings date
- Around Feb 25, 2027
- estimated from its own calendar · quarter ending Dec '26
- Latest stored quarter
- EPS 0.37
- revenue $17.8M · reported Nov 3, 2026
Does this company deliver against its own promises? Earnings are a check on the thesis, not a catalyst to chase.
1 of 1 scored quarter beat.
| Report | Est EPS | Act EPS | Surprise | Est rev | Act rev | Rev surp. | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 3, 20268-K, after close · 4:01 pm ET | −0.32 | 0.37 | +214.8% | $12.2M | $17.8M | +45.5% | +7.8%next session |
| Aug 6, 20268-K, after close · 4:03 pm ET | −0.51 | −0.68 | — | $2.2M | $3.6M | +67.3% | +0.4%next session |
| May 7, 20268-K, after close · 4:03 pm ET | — | −0.69 | — | — | $0.00 | — | −0.5%next session |
| Feb 26, 20268-K, after close · 4:07 pm ET | — | −0.73 | — | — | — | — | −1.1%next session |
| Nov 6, 20258-K, after close · 4:03 pm ET | — | −0.74 | — | — | $0.00 | — | +4.2%next session |
| Aug 11, 20258-K, after close · 4:03 pm ET | — | −0.72 | — | — | $0.00 | — | −5.0%next session |
| May 6, 20258-K, after close · 4:03 pm ET | — | −0.78 | — | — | $0.00 | — | +2.5%next session |
| Feb 4, 2025 E | — | −0.67 | — | — | — | — | —estimated date |
Estimate-vs-actual scoring began Jul 2026 and is still accruing: 1 of the 8 quarters above carries a scored estimate. We never backfill an estimate we didn't observe.
E marks a report date we estimated from the fiscal period end, because we found no results release and no usable filing date for that quarter. Those rows show no reaction: a move measured from a day we guessed is not a reaction to the release, and we would rather leave it blank than publish it.
| Measure | Dec '26 | Mar '27 | FY26 | FY27 |
|---|---|---|---|---|
| No. of analysts | 9 | 2 | 11 | 13 |
| Avg estimate | −0.61 | −0.59 | −1.75 | −2.27 |
| Low estimate | −0.67 | −0.61 | −1.84 | −3.18 |
| High estimate | −0.53 | −0.56 | −1.68 | −1.86 |
| Year-ago EPS | −0.73 | −0.69 | −2.97 | −1.75E |
| Implied growth | — | — | — | — |
| Measure | Dec '26 | Mar '27 | FY26 | FY27 |
|---|---|---|---|---|
| No. of analysts | 12 | 5 | 15 | 15 |
| Avg estimate | $31.7M | $39.3M | $52.6M | $164.3M |
| Low estimate | $28.1M | $34.7M | $29.0M | $83.3M |
| High estimate | $51.9M | $44.2M | $77.2M | $331.8M |
| Year-ago revenue | — | $0.00 | $0.00 | $52.6ME |
| Implied growth | — | — | — | +212.4% |
| Snapshot age | Dec '26, period ending Dec 30, 2026 | Mar '27, period ending Mar 30, 2027 | FY26, period ending Dec 31, 2026 | FY27, period ending Dec 31, 2027 |
|---|---|---|---|---|
| Current estimate | −0.61 | −0.59 | −1.75 | −2.27 |
| 7 days ago | −0.61 | — | −1.77 | −2.30 |
| 30 days ago | −0.63 | — | −2.29 | −2.34 |
| 60 days ago | −0.63 | — | −2.29 | −2.35 |
| 90 days ago | −0.67 | — | −2.41 | −2.44 |
Estimate history accrues from our nightly snapshots. The 7/30/60/90-day rows fill in as tracking continues. Each column follows one fiscal period back through our snapshots; a dash means we had not recorded that period at that age. A rising bar makes a beat streak more meaningful; a falling one manufactures beats.
Dec '26 quarter consensus moved $−0.67 → $−0.61 over 90 tracked days, the same quarter at both ends. Per-analyst up/down revision counts aren't in our data feed. We show the bar's actual movement instead of guessing.
Common questions
When does Denali Therapeutics report earnings next?
Denali Therapeutics' next earnings date is around Feb 25, 2027, estimated from its own calendar.
What were Denali Therapeutics' latest quarterly earnings?
Denali Therapeutics reported diluted EPS of 0.37 and revenue of $17.8M on Nov 3, 2026.
How did Denali Therapeutics' stock move after its last earnings report?
Denali Therapeutics moved +7.8% in the session after its Nov 3, 2026 report.

